Genomic and Transcriptomic Association Studies Identify 16 Novel Susceptibility Loci for Venous Thromboembolism.

Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality. To advance our understanding of the biology contributing to VTE, we conducted a genome-wide association study (GWAS) of VTE and a transcriptome-wide association study (TWAS) based on imputed gene expression from whole blood and liver. We meta-analyzed GWAS data from 18 studies for 30,234 VTE cases and 172,122 controls and assessed the association between 12,923,718 genetic variants and VTE. We generated variant prediction scores of gene expression from whole blood and liver tissue and assessed them for association with VTE. Mendelian randomization analyses were conducted for traits genetically associated with novel VTE loci. We identified 34 independent genetic signals for VTE risk from GWAS meta-analysis of which 14 are newly reported associations. This included 11 newly associated genetic loci (C1orf198, PLEK, OSMR-AS1, NUGGC/SCARA5, GRK5, MPHOSPH9, ARID4A, PLCG2, SMG6, EIF5A, and STX10) of which 6 replicated, and 3 new, independent signals in 3 known genes. Further, TWAS identified 5 additional genetic loci with imputed gene expression levels differing between cases and controls in whole blood (SH2B3, SPSB1, RP11-747H7.3, RP4-737E23.2) and in liver (ERAP1). At some GWAS loci, we found suggestive evidence that the VTE association signal for both novel and previously known regions co-localized with eQTL signals. Mendelian randomization analyses suggested that blood traits may contribute to the underlying risk of VTE. To conclude, we identified 16 novel susceptibility loci for VTE; for some loci, the association signals are likely mediated through gene expression of nearby genes.

[1]  D Y Lin,et al.  Meta‐analysis of genome‐wide association studies: no efficiency gain in using individual participant data , 2009, Genetic epidemiology.

[2]  P. Reitsma,et al.  Genetic variants associated with deep vein thrombosis: the F11 locus , 2009, Journal of thrombosis and haemostasis : JTH.

[3]  O. Melander,et al.  Genetic Variants of Coagulation Factor XI Show Association with Ischemic Stroke Up to 70 Years of Age , 2013, PloS one.

[4]  G. Peck,et al.  The genetics of venous thromboembolism , 2009, Thrombosis and Haemostasis.

[5]  A. J. Slater,et al.  Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals. , 2016, American journal of human genetics.

[6]  Yoav Ben-Shlomo,et al.  Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease. , 2012, American journal of human genetics.

[7]  Matti Pirinen,et al.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity , 2012 .

[8]  T. Lehtimäki,et al.  Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.

[9]  S. Kathiresan,et al.  Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor , 2017, Circulation. Cardiovascular genetics.

[10]  D. Trégouët,et al.  Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels , 2011, Journal of thrombosis and haemostasis : JTH.

[11]  K. Hao,et al.  Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. , 2015, American journal of human genetics.

[12]  L. Jacobsson,et al.  Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? , 2016, Annals of the rheumatic diseases.

[13]  Elena Rossi,et al.  Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives , 2013, Thrombosis and Haemostasis.

[14]  I. Martinelli,et al.  Association between red cell distribution width and risk of venous thromboembolism. , 2015, Thrombosis research.

[15]  D. Trégouët,et al.  The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. , 2012, Blood.

[16]  P. Sullivan,et al.  Heritability and Genomics of Gene Expression in Peripheral Blood , 2014, Nature Genetics.

[17]  Andrew D. Johnson,et al.  Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels , 2019, Circulation.

[18]  Sebastian M. Armasu,et al.  Identification of unique venous thromboembolism-susceptibility variants in African-Americans , 2017, Thrombosis and Haemostasis.

[19]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[20]  F. Dudbridge,et al.  Estimation of significance thresholds for genomewide association scans , 2008, Genetic epidemiology.

[21]  Scott M. Williams,et al.  Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2 , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[23]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[24]  G. Cagney,et al.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.

[25]  Søren Brunak,et al.  Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci , 2016, Nature Genetics.

[26]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[27]  F. Rosendaal,et al.  New gene variants associated with venous thrombosis: a replication study in White and Black Americans , 2011, Journal of thrombosis and haemostasis : JTH.

[28]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[29]  S. Heath,et al.  Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. , 2009, Blood.

[30]  Christian Gieger,et al.  New gene functions in megakaryopoiesis and platelet formation , 2011, Nature.

[31]  L. Melton,et al.  Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. , 1999, Archives of internal medicine.

[32]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[33]  T. Spector,et al.  GENOME-WIDE ASSOCIATION ANALYSES BASED ON WHOLE-GENOME SEQUENCING IN SARDINIA PROVIDE INSIGHTS INTO REGULATION OF HEMOGLOBIN LEVELS , 2015, Nature Genetics.

[34]  N. Timpson,et al.  Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors , 2015, European Journal of Epidemiology.

[35]  Zoltán Kutalik,et al.  Quality control and conduct of genome-wide association meta-analyses , 2014, Nature Protocols.

[36]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[37]  Sebastian M. Armasu,et al.  A genome‐wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q , 2012, Journal of thrombosis and haemostasis : JTH.

[38]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[39]  L. Almasy,et al.  C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. , 2010, Blood.

[40]  F. Cambien,et al.  Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study , 2011, PloS one.

[41]  M. Akiyama,et al.  Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. , 2008, American journal of human genetics.

[42]  D. Strachan,et al.  Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. , 2011, Blood.

[43]  I. Bruns,et al.  Platelet Proteome Analysis Reveals Integrin-dependent Aggregation Defects in Patients with Myelodysplastic Syndromes* , 2013, Molecular & Cellular Proteomics.

[44]  P. Reitsma,et al.  Gene variants associated with deep vein thrombosis. , 2008, Journal of the American Medical Association (JAMA).

[45]  S. Heath,et al.  A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. , 2010, American journal of human genetics.

[46]  G. Davey Smith,et al.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.

[47]  A. Folsom,et al.  Genome‐wide association study with additional genetic and post‐transcriptional analyses reveals novel regulators of plasma factor XI levels , 2017, Human molecular genetics.

[48]  Lorna M. Lopez,et al.  A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. , 2016, Human molecular genetics.

[49]  S. Shapiro,et al.  Venous thromboembolic disease and ABO blood type. A cooperative study. , 1969, Lancet.

[50]  W. März,et al.  The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction. , 2019, Blood.

[51]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[52]  P. Reitsma,et al.  F 9 Malmö , factor IX and deep vein thrombosis , 2022 .

[53]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[54]  T. Lumley,et al.  Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. , 2007, JAMA.

[55]  Scott M. Williams,et al.  Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. , 2012, Blood.

[56]  William W. Cohen,et al.  KNG1 Ile581Thr and susceptibility to venous thrombosis. , 2011, Blood.

[57]  Gary D Bader,et al.  Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.

[58]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[59]  P. Visscher,et al.  Genome-wide complex trait analysis (GCTA): methods, data analyses, and interpretations. , 2013, Methods in molecular biology.

[60]  P. Visscher,et al.  Common SNPs explain a large proportion of heritability for human height , 2011 .

[61]  P. Bagos,et al.  Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis , 2007, Thrombosis and Haemostasis.

[62]  L. Lien,et al.  Amarogentin, a Secoiridoid Glycoside, Abrogates Platelet Activation through PLCγ2-PKC and MAPK Pathways , 2014, BioMed research international.

[63]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[64]  F. Rosendaal,et al.  Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk , 2014, Haematologica.

[65]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[66]  J. Hansen,et al.  Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population , 2014, Thrombosis and Haemostasis.

[67]  James T. Elder,et al.  Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity , 2012, Nature Genetics.

[68]  A. Brown,et al.  Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. , 2016, Human molecular genetics.

[69]  Peter Donnelly,et al.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.

[70]  S. Doucette,et al.  Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty. , 2018, The New England journal of medicine.

[71]  Peter Kraft,et al.  Heritability in the genome-wide association era , 2012, Human Genetics.

[72]  J. Freedman,et al.  Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis , 2018, Circulation research.

[73]  S. Doucette,et al.  Factor XIII Val 34 Leu Variant Is Protective against Venous Thromboembolism : A HuGE Review and Meta-Analysis , 2006 .

[74]  John D. Eicher,et al.  A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology. , 2019, Blood.

[75]  Ming-Huei Chen,et al.  Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium , 2010, Circulation.

[76]  F. Dudbridge.  Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS genetics.

[77]  P. Suksaranjit,et al.  Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis. , 2014, QJM : monthly journal of the Association of Physicians.

[78]  S. Doucette,et al.  Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. , 2006, American journal of epidemiology.

[79]  P. Reitsma,et al.  F9 Malmö, factor IX and deep vein thrombosis , 2009, Haematologica.

[80]  E. Gamazon,et al.  Novel genetic predictors of venous thromboembolism risk in African Americans. , 2016, Blood.

[81]  L. Almasy,et al.  C 4 BPB / C 4 BPA is a new susceptibility locus for venous thrombosis with unknown protein S – independent mechanism : results from genome-wide association and gene expression analyses followed by case-control studies , 2010 .

[82]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[83]  William J. Astle,et al.  Allelic Landscape of Human Blood Cell Trait Variation and Links , 2016 .

[84]  C. Patel.  TM AND HYPERTENSION , 1976, The Lancet.

[85]  Sebastian M. Armasu,et al.  A Genome‐Wide Association Study for Venous Thromboembolism: The Extended Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium , 2013, Genetic epidemiology.

[86]  R. Cavallazzi,et al.  Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis , 2015, PloS one.

[87]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[88]  Akira Meguro,et al.  Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 , 2013, Nature Genetics.

[89]  A. Wolberg,et al.  Red blood cells in thrombosis. , 2017, Blood.

[90]  Christian Gieger,et al.  Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults , 2011, Circulation.

[91]  S. Yurdakul,et al.  Behçet's syndrome: disease manifestations, management, and advances in treatment , 2007, Nature Clinical Practice Rheumatology.

[92]  Andrew P Morris,et al.  Meta-analysis of sex-specific genome-wide association studies , 2010, Genetic epidemiology.

[93]  L. Liang,et al.  A comprehensive survey of genetic variation in 20 , 691 subjects from four large cohorts 1 , 2016 .

[94]  J. Huntington,et al.  Whole-exome sequencing in evaluation of patients with venous thromboembolism. , 2017, Blood advances.

[95]  S. Hall.  Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty. , 2018, The New England journal of medicine.

[96]  O. Egeberg.  THROMBOPHILIA CAUSED BY INHERITABLE DEFICIENCY OF BLOOD ANTITHROMBIN. , 1965, Scandinavian journal of clinical and laboratory investigation.

[97]  J. Houwing-Duistermaat,et al.  Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. , 2005, Blood.

[98]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[99]  Marylyn D. Ritchie,et al.  Imputation and quality control steps for combining multiple genome-wide datasets , 2014, Front. Genet..